Disclosures for "Neurological Efficacy and Safety of RNA Therapeutics in Hereditary Transthyretin Amyloidosis (hATTR): A Systematic Review and Meta-analysis "
-
Maha Sajjad has nothing to disclose.
-
Dr. Nawaz has nothing to disclose.
-
Dr. Hasan has nothing to disclose.
-
Dr. Ashraf has nothing to disclose.
-
Dr. Bhagwan has nothing to disclose.
-
Mr. Ijaz has nothing to disclose.
-
Miss Ejaz has nothing to disclose.
-
Miss Qadeer ud din has nothing to disclose.
-
Mr. Hussain has nothing to disclose.
-
Dr. Ali has nothing to disclose.
-
Author has nothing to disclose